Literature DB >> 22454426

Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.

Michael Katsnelson1, Ralph L Sacco, Mauro Moscucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22454426     DOI： 10.1161/STROKEAHA.111.639864

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  3 in total

1.  Development and validation of a new questionnaire measuring treatment satisfaction in patients with non-valvular atrial fibrillation: SAFUCA®.

Authors:  Miguel A Ruiz; José Ramón González-Porras; José Luis Aranguren; Eduardo Franco; Fernando Villasante; José Tuñón; Tomás José González-López; Marina de Salas-Cansado; Javier Soto
Journal:  Qual Life Res       Date:  2016-12-18       Impact factor: 4.147

Review 2.  Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.

Authors:  Charalampos Kasmeridis; Stavros Apostolakis; Lars Ehlers; Lars H Rasmussen; Giuseppe Boriani; Gregory Y H Lip
Journal:  Pharmacoeconomics       Date:  2013-11       Impact factor: 4.981

3.  A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.

Authors:  Carme Pinyol; Jose Mª Cepeda; Inmaculada Roldan; Vanesa Roldan; Silvia Jimenez; Paloma Gonzalez; Javier Soto
Journal:  Cardiol Ther       Date:  2016-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.